Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:09 AM
Ignite Modification Date:
2025-12-26 @ 11:09 AM
NCT ID:
NCT05205512
Eligibility Criteria:
Inclusion Criteria:
* Diagnosed with Hodgkin or non-Hodgkin lymphoma.
* \>= 18 years old.
* Are between 2-5 years after completing anti-cancer therapy and with no evidence of disease.
* Intermediate (4-5) to high ( \>= 6) risk of cardiovascular risk factors based on six key variables: Age 30 to 50 years (y) \[2\]) and \>= 50y \[3\]; anthracycline dose \>250mg/m \^ 2 \[1\]; hypertension \[2\]; diabetes \[2\]; smoking \[1\]; and chest radiation \[1\]).
* Able to understand and sign the informed consent document.
* Physically able and willing to complete all study procedures.
Exclusion Criteria:
* Have overt cardiovascular disease within 6 months (e.g. myocardial infarction, stroke, angina).
* Have contraindications to exercise.
* Participate in structured exercise (\>60 minutes/week).
* Female patients who are pregnant or planning to become pregnant.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05205512
Study Brief:
Protocol Section:
NCT05205512